International Clinical Trial: A Phase 1, Single-Dose, Open-Label, Randomized, Three-Period, Two-Sequence, Crossover Study to Evaluate the Relative Bioavailability of Paltusotine Low Drug Load (LDL) Tablets 60 mg (2 x 30 mg LDL tablet) and High Drug Load (HDL) Tablet 60 mg (1 x 60 mg HDL tablet) in Healthy Volunteers

Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (ACTRN12625001148460) titled 'A Phase 1, Single-Dose, Open-Label, Randomized, Three-Period, Two-Sequence, Crossover Study to Evaluate the Relative Bioavailability of Paltusotine Low Drug Load (LDL) Tablets 60 mg (2 x 30 mg LDL tablet) and High Drug Load (HDL) Tablet 60 mg (1 x 60 mg HDL tablet) in Healthy Volunteers' on Oct. 21.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial

Primary Sponsor: Crinetics Pharmaceuticals, Inc

Condition: Acromegaly Carcinoid Syndrome Acromegaly Carcinoid Syndrome Metabolic and Endocrine - Other endocrine disorders

Intervention: This is a Phase 1, sing...